BlackRock’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19M Buy
2,082,750
+39,117
+2% +$494K ﹤0.01% 3120
2025
Q4
$28M Buy
2,043,633
+181,887
+10% +$3.37M ﹤0.01% 2893
2025
Q3
$40.6M Buy
1,861,746
+127,595
+7% +$1.5M ﹤0.01% 2632
2025
Q2
$20.7M Buy
1,734,151
+1,323,026
+322% +$16.7M ﹤0.01% 3004
2025
Q1
$4.89M Buy
411,125
+17,862
+5% +$278K ﹤0.01% 3659
2024
Q4
$6.05M Buy
393,263
+21,662
+6% +$281K ﹤0.01% 3645
2024
Q3
$4.17M Buy
371,601
+5,203
+1% +$49.8K ﹤0.01% 3771
2024
Q2
$1.97M Sell
366,398
-1,107,575
-75% -$6.41M ﹤0.01% 3970
2024
Q1
$10M Buy
1,473,973
+3,917
+0.3% +$27.4K ﹤0.01% 3350
2023
Q4
$9.98M Buy
1,470,056
+105,822
+8% +$599K ﹤0.01% 3399
2023
Q3
$6.83M Sell
1,364,234
-9,542
-0.7% -$56.8K ﹤0.01% 3527
2023
Q2
$9.95M Buy
1,373,776
+962,892
+234% +$8.19M ﹤0.01% 3422
2023
Q1
$3.47M Sell
410,884
-1,858
-0.5% -$16.3K ﹤0.01% 3798
2022
Q4
$3.5M Sell
412,742
-78
-0% -$739 ﹤0.01% 3889
2022
Q3
$4.28M Buy
412,820
+115,127
+39% +$1.52M ﹤0.01% 3819
2022
Q2
$3.88M Sell
297,693
-872,160
-75% -$8.91M ﹤0.01% 3939
2022
Q1
$12.2M Sell
1,169,853
-6,502
-0.6% -$59.2K ﹤0.01% 3472
2021
Q4
$13.2M Buy
1,176,355
+12,783
+1% +$191K ﹤0.01% 3509
2021
Q3
$20.7M Buy
1,163,572
+14,362
+1% +$269K ﹤0.01% 3251
2021
Q2
$21.9M Buy
1,149,210
+829,123
+259% +$16M ﹤0.01% 3238
2021
Q1
$6.77M Buy
320,087
+272,022
+566% +$5.82M ﹤0.01% 3799
2020
Q4
$763K Sell
48,065
-1,335
-3% -$12K ﹤0.01% 4276
2020
Q3
$270K Sell
49,400
-472
-0.9% -$2.08K ﹤0.01% 4354
2020
Q2
$177K Buy
49,872
+41,529
+498% +$154K ﹤0.01% 4389
2020
Q1
$30K Buy
8,343
+570
+7% +$2.8K ﹤0.01% 4554
2019
Q4
$37K Buy
+7,773
New +$32.2K ﹤0.01% 4576

Other funds holding CLPT